Ensemble Health Partners vs Omega Healthcare
Two End-to-End RCM vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Ensemble Health Partners | Omega Healthcare | |
|---|---|---|
| Pricing model | Percent of collections · Rate on collections plus incentive tiers | Enterprise contract (custom) · Outsourcing contracts, FTE or outcome based |
| Speed to go live | Full outsourcing with staff transitions | Operational transition to outsourced global teams |
| Automation model | Tech-enabled service · End-to-end RCM operator, EIQ platform | Tech-enabled service · 26,000+ staff plus automation platform |
| Built for | Enterprise systems | Enterprise systems, Payers, Billing companies |
| Security posture | HITRUST, HIPAA | SOC 2 Type II, HITRUST, ISO 27001, HIPAA, PCI DSS |
| Company maturity | 12 yrs (est. 2014) | 23 yrs (est. 2003) |
| Financial backing | PE-backed | PE-owned (Ontario Teachers', Goldman Sachs Alternatives, Everstone) |
| Named customers | 5 named | None public |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 3 listed | None documented |
| Third-party validation | KLAS / analyst cited | KLAS / analyst cited |
Bottom line
- Pick Ensemble if you are a hospital or health system ready to hand the entire revenue cycle, staff included, to an operator paid on collections performance.
- Pick Omega Healthcare if you want to hand entire revenue cycle functions to a proven large-scale outsourcer rather than buy and staff more software.
Ensemble Health Partners
Full-service RCM with operator DNA
- Founded
- 2014
- HQ
- Cincinnati, OH
- Stage
- PE-backed
- Raised
- n/a
What it does
- End-to-end managed revenue cycle for health systems
- Patient access, registration, and financial clearance operations
- Coding, billing, denials prevention, and account resolution
- Proprietary EIQ technology layered on client EHRs
- Embedded operators work inside the client's Epic environment
- New Office of the CFO advisory offering
Where it's strong
- Six consecutive Best in KLAS awards for end-to-end RCM outsourcing, the strongest service reputation in the category.
- Delivers roughly 5% average annual net revenue improvement across clients, with 35 HFMA MAP Awards won by its client base.
- Operator DNA: it was born out of a health system (Bon Secours Mercy Health) rather than a consulting firm.
What buyers should weigh
- Like all full outsourcing, this is a long-term marriage; your revenue cycle staff typically transition to Ensemble.
- Focused on health systems and hospitals; independent physician groups and small specialty practices are outside its model.
- Ownership keeps evolving (Thoreau's 2026 investment is the latest), which buyers should watch for strategy shifts.
Named customers
Bon Secours Mercy Health · Methodist Le Bonheur Healthcare · Hospital Sisters Health System · Benefis Health System · Carilion Clinic
Integrations
Omega Healthcare
Global outsourced revenue cycle, coding, and clinical services
- Founded
- 2003
- HQ
- Boca Raton, FL
- Stage
- PE-owned (Ontario Teachers', Goldman Sachs Alternatives, Everstone)
- Raised
- n/a
What it does
- Medical coding at one of the industry's largest scales
- Billing, charge entry, and AR follow-up
- Denials management and appeals support
- Payer operations and clinical data abstraction
- Workflow automation and analytics over service delivery
Where it's strong
- Scale is the draw: roughly 35,000 trained staff serving 350+ healthcare organizations, with capacity to absorb large coding and AR volumes fast.
- Analyst recognition, including Leader placements in the Everest medical coding PEAK Matrix and the 2025-2026 IDC MarketScape for US RCM services.
- Pairs offshore labor arbitrage with automation, so unit costs are hard for onshore vendors to match.
What buyers should weigh
- Delivery is heavily offshore, which some organizations restrict for PHI handling or contract policy reasons; review data governance closely.
- It is a services company, not a software product, so results depend on the specific team and account management you get.
- Private equity ownership with a 2025 stake sale means strategy and pricing pressure can shift with the ownership cycle.
Compare against the rest of End-to-End RCM
Deciding between these two?
First Pass tracks End-to-End RCM every week: funding, launches, and what changed since this page was written.